Pupil Dilation for Treatment of IFIS

ClinicalTrials.gov ID: NCT03760185

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03760185. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Enhanced Pupil Dilation in Patients Taking Alpha-Blockers for Potential Treatment of Intraoperative Floppy Iris Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.

Study identification

NCT ID: NCT03760185
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Denver Health and Hospital Authority; Other
Enrollment: 13 participants

Conditions and interventions

Conditions

Intraoperative Floppy Iris Syndrome

Interventions

Brimonidine Tartrate Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 100 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 4, 2019 (Actual)
Primary completion: Sep 25, 2020 (Actual)
Completion: Sep 25, 2020 (Actual)
Last update posted: Apr 20, 2022

2019 – 2020

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Denver Health	Denver	Colorado	80204	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03760185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 20, 2022 · Synced Nov 12, 2026